Clinical Trials on Hypercholesterolemia in Coronaory Heart Disease

Total 77044 results

1
2
3
4
5
6
7
8
9
10
...
1540
1541
›

Zhejiang Hisun Pharmaceutical Co. Ltd.

Completed

Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases (HS-25-III-02)

Hypercholesterolemia in Coronaory Heart Disease
Shanghai Rona Therapeutics Co., Ltd.
SHANGHAI RONA Therapeutics Co.,Ltd.

Completed

the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

To Reduce the LDL-C Level in Hypercholesteremia Patients

China
AstraZeneca
Shionogi

Completed

Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

Hypercholesteremia

Japan
Astellas Pharma Inc

Completed

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

Coronary Artery Disease | Hypercholesteremia

Japan
Geisinger Clinic

Completed

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

Hypercholesterolemia | Hypercholesterolemia, Familial | Hypercholesteremia in Children | Hyperlipidemia in Children

United States
Ikaria Bioscience Pty Ltd

Completed

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other Comorbidities

Australia
Lescuyer Laboratory
BioFortis

Completed

Dose Effect of Limicol on (LDL)-Cholesterol Levels

Hypercholesterolaemia

France
Nantes University Hospital
France 2030 program; European Union Next Generation

Not yet recruiting

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study) (ATHERO-FH)

Familial Hypercholesterolemias | Atherosclerotic Cardiovascular Disease (ASCVD)

France
Organon and Co

Completed

A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

Primary Hypercholesterolemia
University of Ioannina
University Hospital, Ioannina

Completed

The Effect of Childhood Dyslipidemia on Endothelial and Renal Function

Dyslipidemias | Endothelial Dysfunction | Children, Only | Renal Dysfunction | Hypercholesteremia in Children

Greece
Novartis Pharmaceuticals

Recruiting

LATAM LOWERS LDL-C

Hypercholesterolaemia

Argentina, Brazil
Lescuyer Laboratory
Aix Marseille Université; CIC Hôpital de la Conception - Marseille

Completed

Effects of Limicol on LDL-cholesterol

Hypercholesteremia

France
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting (ATTENTION)

Coronary Artery Disease, Hypercholesterolemia, Hypertension

China
Sanofi
Regeneron Pharmaceuticals

Completed

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Hypercholesterolaemia

United States
GlaxoSmithKline

Completed

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Hypercholesterolaemia

India
AstraZeneca

Completed

Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Hypercholesterolaemia

Singapore
AstraZeneca

Completed

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Hypercholesterolaemia
Moon (Guangzhou) Biotechnology Co., Ltd.

Not yet recruiting

An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia (AKM Lab-01)

Hypercholesterolaemia
Akeso
AD Pharmaceuticals Co., Ltd.

Completed

A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Hypercholesterolaemia

China
GlaxoSmithKline

Completed

Rosuvastatin Calcium Bioequivalence Study - Fast

Hypercholesterolaemia

Brazil
AstraZeneca

Completed

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Hypercholesterolaemia

Bosnia and Herzegovina
AstraZeneca

Completed

Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors

Hypercholesterolaemia

Croatia
AstraZeneca

Completed

Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients (RESEARCH)

Hypercholesterolaemia

Greece
AstraZeneca

Completed

OLE Study to Evaluate Safety / Efficacy of ZD4522

Hypercholesterolaemia
AtheroNova Inc.

Unknown

Safety Study of Bile Acid to Treat Hypercholesteremia

Hypercholesterolemia

Russian Federation
Novartis Pharmaceuticals

Active, not recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

Hypercholesterolaemia | Familial Hypercholesterolaemia

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

Hypercholesterolaemia

France, Belgium, Netherlands
AstraZeneca

Terminated

Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

Hypercholesterolaemia

United Kingdom
B. Braun Medical Inc.
Infraredx; Bright Research Partners

Withdrawn

Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment (RESPECT-ISR)

Coronary Artery Restenosis | In-stent Restenosis | In-stent Coronary Artery Restenosis
Addpharma Inc.

Not yet recruiting

A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

Primary Hypercholesterolaemia

Korea, Republic of
Addpharma Inc.

Recruiting

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

Primary Hypercholesterolaemia

Korea, Republic of
Amgen

Terminated

Study to Evaluate the Safety of Repatha® in Pregnancy

Pregnancy | Hypercholesterolaemia

Belgium, Denmark, Italy, Czechia, United Kingdom, Australia, Austria, Greece, Switzerland, Netherlands, Spain, Sweden, Slovakia, Norway
AstraZeneca

Withdrawn

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Primary Hypercholesterolaemia
Hyundai Pharm

Not yet recruiting

To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients with Essential Hypertension and Primary Hypercholesterolemia (HODO-2224)

Hypertension | Primary Hypercholesterolaemia
Jiangsu HengRui Medicine Co., Ltd.

Completed

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

Hypercholesteremia

China
AstraZeneca

Completed

Pattern of Statins Use in Catalonia

Hypercholesteremia
AstraZeneca

Completed

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Hypercholesteremia

United States, France, Norway, Netherlands, Belgium, Germany, Finland, Czech Republic
AstraZeneca

Completed

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Hypercholesteremia

Belgium
AstraZeneca

Completed

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Hypercholesteremia
AstraZeneca

Completed

Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia (CEPHEUS)

Undertreatment of Hypercholesterolaemia

South Africa
NeuroBo Pharmaceuticals Inc.

Completed

A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins (ROYAL-1)

Hypercholesteremia

United States
NeuroBo Pharmaceuticals Inc.

Completed

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

Hypercholesteremia
Amgen

Completed

Chart Review of Repatha® in Subjects With Hyperlipidaemia (HEYMANS)

Hypercholesterolaemia

Austria, Italy, Belgium, Czechia, Switzerland, Spain, Slovakia, Germany, Portugal, Greece, Bulgaria, Sweden
Novo Nordisk A/S

Completed

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Healthy Volunteers | Hypercholesterolaemia

United Kingdom
Merck Sharp & Dohme LLC

Recruiting

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Arteriosclerosis | Hypercholesterolaemia

United States, Taiwan, Canada, Israel, New Zealand, Hong Kong, Argentina, Korea, Republic of, Turkey, Chile, Australia, Brazil, Colombia, Italy, Spain, China, United Kingdom, Mexico, Peru, South Africa, Norway, Denmark, Hungary, Nethe... and more
The Cooper Institute
Cargill

Completed

Phytosterol Supplementation and Cardiovascular Risk

Hypercholesteremia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Population-Based Modeling of Cholesterol Lowering in the United States

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypercholesterolemia | Coronary Heart Disease Risk Reduction
Organon and Co

Completed

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

Hypercholesterolaemia | Hyperlipidaemia
Danone Research

Completed

Pilot Study in the Cholesterol Absorption Reduction After Consumption of Low-fat, Drinkable Fermented Milk Enriched With Plant Sterols

Mildly Hypercholesterolemic Subjects

Canada
Danone Research

Completed

Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults

Mildly Hypercholesterolemic Subjects

United Kingdom

1
2
3
4
5
6
7
8
9
10
...
1540
1541
›

Clinical Trials on Hypercholesterolemia in Coronaory Heart Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations